The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
1/10. Predicted molecular weight: 13 kDa. Use under reducing conditions.
Use at an assay dependent concentration.
Is unsuitable for IHC-Fr.
Neutrophil and pancreatic elastase-specific inhibitor of skin. It may prevent elastase-mediated tissue proteolysis.
Contains 1 WAP domain.
Consists of two domains: the transglutaminase substrate domain (cementoin moiety) and the elastase inhibitor domain. The transglutaminase substrate domain serves as an anchor to localize elafin covalently to specific sites on extracellular matrix proteins.